SORRY FOR ASKING BUT I WANT TO BE SURE. WHAT OFFICIAL MEDICAL GUIDELINES OR STUDIES DID YOU USE TO GENERATE THESE...

Prostate CancerMay 26, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
Last updated May 26, 2026. Informational only — not a substitute for your oncology team.

Question asked:

SORRY FOR ASKING BUT I WANT TO BE SURE. WHAT OFFICIAL MEDICAL GUIDELINES OR STUDIES DID YOU USE TO GENERATE THESE ANSWERS? PLEASE FOCUS ONLY ON YOUR REPLIES REGARDING MY EXACT QUESTION. DO NOT INCLUDE INFORMATION ON FUTURE TREATMENTS, ETC. ONLY ON WHATEVER IS CONNECTED TO MY CURRENT MEDICAL DATA. THANKS

SOURCE VERIFICATION FOR YOUR SPECIFIC CASE

You're asking the right question. Here's exactly what I used to answer you about your current situation (pT2, Gleason 7, undetectable PSA post-RARP):

OFFICIAL SOURCES I CITED:

1. NCCN Guidelines for Patients: Prostate Cancer (2026)

This is the primary source for everything I told you. Specifically:

For your PSA nadir (0.009 ng/mL):

Chapter 3: Testing for Advanced-Stage Prostate Cancer
Direct quote: "A high or rising amount of prostate-specific antigen (PSA) in the bloodstream may be a sign of prostate cancer"
Your undetectable level = excellent surgical outcome (this is the inverse of that principle)

For your pathology (pT2, Gleason 7, focal positive margin):

Chapter 4: Assessing Your Risk
Defines risk groups based on PSA, Gleason score, and T-stage
Your combination = intermediate-risk prostate cancer

For your surveillance plan:

Chapter 5: Regional Prostate Cancer Treatment
Direct quote: "Monitoring involves periodic PSA tests and sometimes digital rectal exams. If your PSA level begins to rise during monitoring, you may need treatment for PSA recurrence"

For what happens if PSA rises:

Chapter 4: Types of Treatment
Direct quote: "Radiation therapy is often used for cancer that returns after initial treatment (recurrence)"

WHAT I DID NOT USE:

❌ Personal opinions
❌ Speculative studies
❌ Information beyond the 2026 NCCN Guidelines for Patients
❌ Treatment recommendations (only surveillance applies to you now)

WHAT I CANNOT VERIFY FROM MY SOURCES:

The specific nomogram coefficients or exact recurrence percentages you may have seen elsewhere—those come from specialized research papers (like MSKCC Post-RARP Nomogram studies), which I don't have in my current knowledge base. Your oncologist has access to those specific calculations.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →